COPOLYMÈRES POLYDIALLYMINE RÉTICULÉ POUR LE TRAITEMENT DU DIABÈTE DE TYPE 2

Polydiallylamine copolymers are copolymers comprising monomers of polydiallylamine and either polyvinlyamine or polyallylamine. Polydiallylamine copolymers are often crosslinked. The polydiallyamine copolymers are useful as pharmaceutical compositions and may be used in the treatment of type 2 diabe...

Full description

Saved in:
Bibliographic Details
Main Authors LARSEN, Philip Just, MILLER, Robert J, DAVISON, Ian, POLOMOSCANIK, Steven C, SCHMIDT, Thorsten, HUEBSCHLE, Thomas, DHAL, Pradeep K, AGBUGBA, Chinyere, MCDONNELL, Peter
Format Patent
LanguageFrench
Published 24.10.2017
Subjects
CHEMISTRY
COMPOSITIONS BASED THEREON
HUMAN NECESSITIES
HYGIENE
MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVINGCARBON-TO-CARBON UNSATURATED BONDS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC MACROMOLECULAR COMPOUNDS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
THEIR PREPARATION OR CHEMICAL WORKING-UP
Online AccessGet full text

Cover

More Information
Summary:Polydiallylamine copolymers are copolymers comprising monomers of polydiallylamine and either polyvinlyamine or polyallylamine. Polydiallylamine copolymers are often crosslinked. The polydiallyamine copolymers are useful as pharmaceutical compositions and may be used in the treatment of type 2 diabetes and for mitigating the complications of type 2 diabetes.
Bibliography:Application Number: MA20150041202